| P2093 | author name string | Rui Chen | |
| | Liang Li | |
| | Mei Zhao | |
| | Wei Zhao | |
| | Lin Fan | |
| | Xiang-Ming Che | |
| P2860 | cites work | Diabetes and cancer | Q84262739 |
| | Gastric cancer | Q84276928 |
| | Expression of SIRT1 in gastric cardiac cancer and its clinicopathologic significance | Q84818660 |
| | Insulin use and cancer risk in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies | Q27025720 |
| | Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 |
| | p53 mutations in human cancers | Q28302973 |
| | RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response. | Q33186000 |
| | The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth | Q34095570 |
| | Activating transcription factor 4 confers a multidrug resistance phenotype to gastric cancer cells through transactivation of SIRT1 expression | Q34170941 |
| | SIRT1 and p53, effect on cancer, senescence and beyond | Q34341091 |
| | The NAD World: a new systemic regulatory network for metabolism and aging--Sirt1, systemic NAD biosynthesis, and their importance | Q34917651 |
| | Dissecting systemic control of metabolism and aging in the NAD World: the importance of SIRT1 and NAMPT-mediated NAD biosynthesis | Q35013606 |
| | The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop | Q35709058 |
| | The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study | Q36001145 |
| | Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor | Q36126134 |
| | Therapy insight: Influence of type 2 diabetes on the development, treatment and outcomes of cancer | Q36303910 |
| | Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells | Q36379543 |
| | Diet-induced obesity potentiates the growth of gastric cancer in mice | Q36409245 |
| | SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolism | Q37002755 |
| | Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India | Q37135934 |
| | Nampt: linking NAD biology, metabolism and cancer | Q37334248 |
| | New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives | Q37725910 |
| | Nampt/PBEF/visfatin and cancer | Q37774515 |
| | Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer | Q38000089 |
| | DNA repair and resistance to topoisomerase I inhibitors: mechanisms, biomarkers and therapeutic targets. | Q38025707 |
| | The NAD metabolome--a key determinant of cancer cell biology | Q38047182 |
| | Diabetes mellitus and cancer risk: review of the epidemiological evidence | Q38052155 |
| | Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma | Q38494370 |
| | Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil | Q39509326 |
| | A novel role for the adipokine visfatin/pre-B cell colony-enhancing factor 1 in prostate carcinogenesis | Q39788991 |
| | Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells | Q39932777 |
| | A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells | Q39969180 |
| | Genetic variation in the visfatin (PBEF1/NAMPT) gene and type 2 diabetes in the Greek population | Q43069677 |
| | [Detection of P-glycoprotein and its clinical significance] | Q73346881 |
| | Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia | Q80505050 |
| P433 | issue | 1 | |
| P304 | page(s) | 843-850 | |
| P577 | publication date | 2015-03-20 | |
| P1433 | published in | Molecular Medicine Reports | Q26842180 |
| P1476 | title | High glucose promotes gastric cancer chemoresistance in vivo and in vitro | |
| P478 | volume | 12 | |